Adma Biologics | ADMA - Operating Expenses

Stock Price
15.72
Daily Change
0.57 3.73%
Monthly
-1.47%
Yearly
-15.83%
Q1 Forecast
14.69

Adma Biologics reported $83.21M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Adma Biologics USD 83.21M 4.02M Sep/2025
Alnylam Pharmaceuticals USD 965.32M 84.27M Dec/2025
BioCryst Pharmaceuticals USD 146.17M 534.06M Dec/2025
Minerva Neurosciences USD 4.52M 155.46K Dec/2024
Novavax USD 126.2M 23.62M Dec/2025
Omeros USD 59.16M 20.13M Jun/2024
Takeda JPY 1.02T 400.98B Dec/2025